Attends Healthcare

Investment Info

Attends Healthcare Group logo

A European leader in the manufacture and supply of branded and own label incontinence products.

Sector:  Healthcare Products

Deal Value:  £94 million

Transaction:  Capex-led turnaround

Fund:  RFII

Exit Date:  January 2012

Exit Value:  £180 million

Exit Route:  Canadian trade buyer (Domtar)

Company website:  Attends

Investment Contact
Investment Contact